Shalabh K. Gupta - 12 Jul 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role: CEO & President, Director
Signature: /s/ Shalabh Gupta
Issuer symbol: UNCY
Transactions as of: 12 Jul 2021
Net transactions value: $0
Form type: 3
Filing time: 12 Jul 2021, 17:13:32 UTC
Next filing: 26 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	UNCY	Common Stock						2,321,092	12 Jul 2021	Direct
holding	UNCY	Common Stock						1,474,745	12 Jul 2021	By New Castle Health Care LLC
holding	UNCY	Common Stock						69,768	12 Jul 2021	By Arete Healthcare Innovation Trust
holding	UNCY	Common Stock						1,901,509	12 Jul 2021	By Seedbio LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	UNCY	Employee Stock Option (right to buy)							12 Jul 2021	Common Stock	101,744	$0.0100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the stock options reported in Table II, Column 3 vested on August 1, 2019, and the remaining seventy-five percent (75%) of stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on August 1, 2022.